NCT07866638: Suzetrigine for Analgesiain Arthroscopic Rotator Cuff Repair

Summary

The goal of this prospective is to determinate if Suzetrigine decreased de use of opioids in patients that undergo an arthroscopic rotator cuff repair. The main question it aims to answer: Does Suzetrigine lower the number of times participants need to use opioid? If there is a comparison group: Researchers will compare study drug group to see if, will reduce opioid utilization during the inpatient period and at discharge without worsening pain control, compared with multimodal analgesia alone. Participants will take study drug before procedure and for 13 days afterwards.

Timeline

Start: 2026-11-01
Primary completion: 2028-09-01
Completion: 2028-09-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Suzetrigine	Small molecule	50 mg	Oral
Background	Acetaminophen	Small molecule	1000 mg	—
Background	Gabapentin	Unknown	100 mg	—
Background	Methocarbamol	Small molecule	750 mg	—
Background	Oxycodone	Other / unclassified	5 mg	—

Indications

No indication recorded.